Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.

Animals Chemokine CXCL13 / immunology Female Granuloma / immunology Humans Immunity, Innate / immunology Interleukin-17 / immunology Interleukins / immunology Lung / immunology Lymphocytes / classification Macrophages, Alveolar / immunology Male Mice Mycobacterium tuberculosis / immunology Receptors, CXCR5 / immunology Transcriptome / genetics Tuberculosis, Pulmonary / genetics Interleukin-22

Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
06 2019
Historique:
received: 02 05 2018
accepted: 10 05 2019
pubmed: 7 6 2019
medline: 5 3 2020
entrez: 7 6 2019
Statut: ppublish

Résumé

Tuberculosis is the leading cause of death by an infectious disease worldwide

Identifiants

DOI: 10.1038/s41586-019-1276-2 PMID: 31168092 PMC: PMC6626542
pubmed: 31168092
doi: 10.1038/s41586-019-1276-2
pii: 10.1038/s41586-019-1276-2
pmc: PMC6626542
mid: NIHMS1529144
doi:

Substances chimiques

CXCL13 protein, human 0
CXCR5 protein, human 0
Chemokine CXCL13 0
Cxcl13 protein, mouse 0
Interleukin-17 0
Interleukins 0
Receptors, CXCR5 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-532

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI134236
Pays : United States
Organisme : Wellcome Trust
ID : 210662/Z/18/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI111914
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007317
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105427
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007163
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007172
Pays : United States
Organisme : NIAID NIH HHS
ID : U24 AI118672
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI091036
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL139930
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI123780
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Références

Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
Nat Immunol. 2016 Jun 21;17(7):765-74
pubmed: 27328006
J Leukoc Biol. 2010 Aug;88(2):227-32
pubmed: 20299682
Cell Host Microbe. 2015 Jul 8;18(1):15-26
pubmed: 26159717
Oncol Lett. 2016 Mar;11(3):2199-2206
pubmed: 26998149
Nature. 2010 Jan 28;463(7280):540-4
pubmed: 20023630
J Exp Med. 2009 Jan 16;206(1):35-41
pubmed: 19114665
Immunity. 2016 Feb 16;44(2):391-405
pubmed: 26850658
Immunology. 2016 Feb;147(2):141-51
pubmed: 26551738
J Exp Med. 2010 Apr 12;207(4):777-92
pubmed: 20351059
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
J Clin Invest. 2014 Mar;124(3):1268-82
pubmed: 24509076
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Immunity. 2014 Sep 18;41(3):354-365
pubmed: 25238093
Nat Immunol. 2011 Nov;12(11):1045-54
pubmed: 21946417
Nat Immunol. 2015 Nov;16(11):1124-33
pubmed: 26414766
Immunity. 2013 Aug 22;39(2):357-71
pubmed: 23954132
J Immunol. 2010 Jul 15;185(2):929-42
pubmed: 20554962
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Eur J Immunol. 2008 May;38(5):1321-30
pubmed: 18398932
Blood. 2006 Nov 1;108(9):3168-75
pubmed: 16825490
Scand J Immunol. 2003 Nov;58(5):522-32
pubmed: 14629624
Am J Respir Cell Mol Biol. 2015 Oct;53(4):479-88
pubmed: 25692402
J Biol Chem. 2013 Jan 11;288(2):1374-84
pubmed: 23168411
Nat Immunol. 2007 Apr;8(4):369-77
pubmed: 17351619
J Clin Invest. 2013 Feb;123(2):712-26
pubmed: 23281399
Genes Immun. 2015 Jul-Aug;16(5):347-55
pubmed: 26043170
Nat Immunol. 2009 Jan;10(1):66-74
pubmed: 19029905

Auteurs

Amanda Ardain (A)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Racquel Domingo-Gonzalez (R)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Shibali Das (S)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Samuel W Kazer (SW)

Institute for Medical Engineering and Science, Department of Chemistry, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Nicole C Howard (NC)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Alveera Singh (A)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Mushtaq Ahmed (M)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Shepherd Nhamoyebonde (S)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Javier Rangel-Moreno (J)

Division of Allergy, Immmunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Paul Ogongo (P)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya.

Lan Lu (L)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Duran Ramsuran (D)

School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Maria de la Luz Garcia-Hernandez (M)

Division of Allergy, Immmunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Tyler K Ulland (T)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Matthew Darby (M)

IDM, University of Cape Town, Cape Town, South Africa.

Eugene Park (E)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, MO, USA.

Farina Karim (F)

Africa Health Research Institute, Durban, South Africa.

Laura Melocchi (L)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Rajhmun Madansein (R)

Department of Cardiothoracic Surgery, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Kaylesh Jay Dullabh (KJ)

Department of Cardiothoracic Surgery, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Micah Dunlap (M)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Nancy Marin-Agudelo (N)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.

Takashi Ebihara (T)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, MO, USA.

Thumbi Ndung'u (T)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Deepak Kaushal (D)

Tulane National Primate Research Center, Covington, LA, USA.

Alexander S Pym (AS)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Jay K Kolls (JK)

Tulane University Health Sciences, New Orleans, LA, USA.

Adrie Steyn (A)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Department of Microbiology, Centres for AIDS Research and Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA.

Joaquín Zúñiga (J)

Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.

William Horsnell (W)

IDM, University of Cape Town, Cape Town, South Africa.
Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Wayne M Yokoyama (WM)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, MO, USA.
Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Alex K Shalek (AK)

Institute for Medical Engineering and Science, Department of Chemistry, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Henrik N Kløverpris (HN)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Department of Infection and Immunity, University College London, London, UK.

Marco Colonna (M)

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

Alasdair Leslie (A)

Africa Health Research Institute, Durban, South Africa. al.leslie@ahri.org.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa. al.leslie@ahri.org.
Department of Infection and Immunity, University College London, London, UK. al.leslie@ahri.org.

Shabaana A Khader (SA)

Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. sakhader@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Chimiokines › Chimiokines CXC › Chimiokine CXCL13 › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Granulome › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité innée › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-17 › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Appareil respiratoire › Poumon › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Phagocytes › Macrophages › Macrophages alvéolaires › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux cytokines › Récepteurs aux chimiokines › Récepteurs CXCR › Récepteurs CXCR5 › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Transcriptome › Group 3 innate lymphoid cells mediate early...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Tuberculose pulmonaire › Group 3 innate lymphoid cells mediate early...